[1]
|
Lane, C.A., Hardy, J. and Schott, J.M. (2018) Alzheimer’s Disease. European Journal of Neurology, 25, 59-70.
https://doi.org/10.1111/ene.13439
|
[2]
|
马英, 曹云鹏. 阿尔茨海默病的神经免疫炎症发病机制及其治疗研究进展[J]. 中国老年学杂志, 2010, 30(21): 3200-3204.
|
[3]
|
洪萍, 王培昌. 阿尔茨海默病蛋白标志物研究进展[J]. 中华临床实验室管理电子杂志, 2014, 2(2): 28-30.
|
[4]
|
Martinez, B. and Peplow, P.V. (2019) Amelioration of Alzheimer’s Disease Pathology and Cognitive Deficits by Immunomodulatory Agents in Animal Models of Alzheimer’s Disease. Neural Regeneration Research, 14, 1158-1176.
https://doi.org/10.4103/1673-5374.251192
|
[5]
|
Li, D., Li, Y.P., Li, Y.X., et al. (2018) Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases. Chinese Medical Journal, 131, 2216-2225. https://doi.org/10.4103/0366-6999.240817
|
[6]
|
Zhang, N., Li, W.W., Lv, C.M., Gao, Y.W., Liu, X.L. and Zhao, L. (2020) miR-16-5p and miR-19b-3p Prevent Amyloid β-Induced Injury by Targeting BACE1 in SH-SY5Y Cells. Neuroreport, 31, 205-212.
https://doi.org/10.1097/WNR.0000000000001379
|
[7]
|
徐静, 吴玉泉, 许娟, 等. 阿尔茨海默病患者血清miR-19b-3p表达与认知功能的关系[J]. 中华行为医学与脑科学杂志, 2017, 26(11): 994-998.
|
[8]
|
Wu, Y., Xu, J., Xu, J., et al. (2017) Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer’s Disease. The Tohoku Journal of Experimental Medicine, 242, 129-136. https://doi.org/10.1620/tjem.242.129
|
[9]
|
张燕琼, 文建凡. 单细胞真核生物的miRNA系统及其进化意义[J]. 动物学研究, 2010, 31(1): 39-42.
|
[10]
|
Lee, Y., Kim, M., Han, J., et al. (2004) MicroRNA Genes Are Transcribed by RNA Polymerase II. EMBO Journal, 23, 4051-4060. https://doi.org/10.1038/sj.emboj.7600385
|
[11]
|
Lee, Y., Ahn, C., Han, J., et al. (2003) The Nuclear RNase III Drosha Initiates microRNA Processing. Nature, 425, 415-419. https://doi.org/10.1038/nature01957
|
[12]
|
Bernstein, E., Caudy, A.A., Hammond, S.M. and Hannon, G.J. (2001) Role for a Bidentate Ribonuclease in the Initiation Step of RNA Interference. Nature, 409, 363-366. https://doi.org/10.1038/35053110
|
[13]
|
汪元浚, 杨发满, 董庆玲, 等. microRNA-15a在阿尔茨海默病中的作用及机制[J]. 中国老年学杂志, 2018, 38(7): 1733-1735.
|
[14]
|
Kou, X., Chen, D. and Chen, N. (2020) The Regulation of microRNAs in Alzheimer’s Disease. Frontiers in Neurology, 11, Article No. 288. https://doi.org/10.3389/fneur.2020.00288
|
[15]
|
Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C. and Ruberti, F. (2010) MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons. Journal of Biological Chemistry, 285, 18344-18351.
https://doi.org/10.1074/jbc.M110.112664
|
[16]
|
李娜. 基于“Aβ级联假说”的中药治疗阿尔茨海默病研究进展[J]. 中国中西医结合杂志, 2011, 31(12): 1714-1720.
|
[17]
|
Wilcox, K.C., Lacor, P.N., Pitt, J. and Klein, W.L. (2011) Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease. Cellular and Molecular Neurobiology, 31, 939-948. https://doi.org/10.1007/s10571-011-9691-4
|
[18]
|
Li, W., Li, X., Xin, X., Kan, P.C. and Yan, Y. (2016) MicroRNA-613 Regulates the Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease. BioScience Trends, 10, 372-377. https://doi.org/10.5582/bst.2016.01127
|
[19]
|
Coimbra, J., Marques, D., Baptista, S.J., et al. (2018) Highlights in BACE1 Inhibitors for Alzheimer’s Disease Treatment. Frontiers in Chemistry, 6, Article No. 178. https://doi.org/10.3389/fchem.2018.00178
|
[20]
|
蔺莹, 姚璎珈, 梁喜才, 等. 蛇床子素上调miRNA-9抑制BACE-1表达治疗阿尔茨海默病[J]. 中国药理学通报, 2019, 35(4): 524-529.
|
[21]
|
Revett, T.J., Baker, G.B., Jhamandas, J. and Kar, S. (2013) Glutamate System, Amyloid β Peptides and Tau Protein: Functional Interrelationships and Relevance to Alzheimer Disease Pathology. Journal of Psychiatry & Neuroscience, 38, 6-23. https://doi.org/10.1503/jpn.110190
|
[22]
|
Gui, Y., Liu, H., Zhang, L., Lv, W. and Hu, X. (2015) Altered microRNA Profiles in Cerebrospinal Fluid Exosome in Parkinson Disease and Alzheimer Disease. Oncotarget, 6, 37043-37053. https://doi.org/10.18632/oncotarget.6158
|
[23]
|
Rahman, M.R., Islam, T., Turanli, B., et al. (2019) Network-Based Approach to Identify Molecular Signatures and Therapeutic Agents in Alzheimer’s Disease. Computational Biology and Chemistry, 78, 431-439.
https://doi.org/10.1016/j.compbiolchem.2018.12.011
|
[24]
|
Iqbal, K., Liu, F. and Gong, C.X. (2016) Tau and Neurodegenerative Disease: The Story So Far. Nature Reviews Neurology, 12, 15-27. https://doi.org/10.1038/nrneurol.2015.225
|
[25]
|
李雪娇, 郎咸圣婕, 张宪亮. miRNA在阿尔茨海默病中的研究进展[J]. 中国老年学杂志, 2021, 41(13): 2883-2888.
|
[26]
|
张蒙, 寇现娟. MiRNA在阿尔茨海默症发病机制中的作用[J]. 生命的化学, 2020, 40(9): 1547-1557.
|
[27]
|
Drewes, G., Lichtenberg-Kraag, B., Döring, F., et al. (1992) Mitogen Activated Protein (MAP) Kinase Transforms Tau Protein into an Alzheimer-Like State. EMBO Journal, 11, 2131-2138.
https://doi.org/10.1002/j.1460-2075.1992.tb05272.x
|
[28]
|
Hernández, F. and Avila, J. (2007) Tauopathies. Cellular and Molecular Life Sciences, 64, 2219-2233.
https://doi.org/10.1007/s00018-007-7220-x
|
[29]
|
梁春联, 朱华, 黄澜, 等. MicroRNA-153对靶基因下游信号分子GSK-3β表达水平及细胞抗损伤能力的影响[J]. 中国比较医学杂志, 2011, 21(8): 15-19.
|
[30]
|
Hernandez, P., Lee, G., Sjoberg, M. and Maccioni, R.B. (2009) Tau Phosphorylation by cdk5 and Fyn in Response to Amyloid Peptide Abeta (25-35): Involvement of Lipid Rafts. Journal of Alzheimer’s Disease, 16, 149-156.
https://doi.org/10.3233/JAD-2009-0933
|
[31]
|
Zhou, Y., Deng, J., Chu, X., Zhao, Y. and Guo, Y. (2019) Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 67, 571-581.
https://doi.org/10.3233/JAD-181053
|
[32]
|
Wanet, A., Tacheny, A., Arnould, T. and Renard, P. (2012) miR-212/132 Expression and Functions: Within and beyond the Neuronal Compartment. Nucleic Acids Research, 40, 4742-4753. https://doi.org/10.1093/nar/gks151
|